MétaCan
Menu
Back to cohort
Record W1560703376 · doi:10.5772/21715

Inducing Immune Protection Against Trichomonas vaginalis: A Novel Vaccine Approach to Prevent HIV Transmission

2011· book-chapter· en· W1560703376 on OpenAlexaff
Sarah L. Cudmore, Jeffrey Smith, Gary Garber

Bibliographic record

VenueInTech eBooks · 2011
Typebook-chapter
Languageen
FieldImmunology and Microbiology
TopicReproductive tract infections research
Canadian institutionsUniversity of Ottawa
Fundersnot available
KeywordsTrichomonas vaginalisHuman immunodeficiency virus (HIV)Transmission (telecommunications)VirologyImmune systemMedicineImmunologyBiologyMicrobiologyComputer scienceTelecommunications

Abstract

fetched live from OpenAlex

Human immunodeficiency virus (HIV) infection is a pandemic that affects all parts of the globe. Current treatments fail to cure disease and for this reason there is significant interest in producing a vaccine to prevent HIV transmission, but clinical trials have proved disappointing. For this reason it is important to consider alternative measures to control incidence and prevalence of the disease. Trichomonas vaginalis is a highly prevalent and under-diagnosed sexually transmitted infection that facilitates transmission of and susceptibility to HIV infection Although current treatment is effective the disease is still poorly controlled and there are concerns about increasing levels of drug resistance Efforts to research disease mechanisms and immune response with consideration to a rational vaccine design approach should be investigated as a potential method to reduce global incidence of T. vaginalis infection. A reliable murine model of T. vaginalis infection has been established with symptoms in female mice mimicking those seen in women (from vaginitis/vulvitis and discharge to asymptomatic but culture-positive for infection). Using this model it has been shown that vaccinating mice (by injection of trichomonad cells with adjuvant) protects the animals from subsequent vaginal infection By studying immune responses in mice, factors that are critical for immunological protection can be elucidated to create a "blueprint" for an effective human vaccine. Herein we provide an overview of the current understanding of T. vaginalis infection and epidemiology, methods of diagnosis and treatment, and implications of animal models for understanding disease mechanisms . We discuss how and why current T. vaginalis treatment protocols fail to control infection incidence with consideration as to how a T. vaginalis vaccine could overcome these obstacles and reduce disease burden. The association between T. vaginalis and HIV is examined and the potential for reducing HIV infection rates by lowering T. vaginalis incidence is elucidated. A vaccine against T. vaginalis would provide long term protection that could be more successful than treatment in controlling the spread of this very common disease. As T. vaginalis infection is a clear risk factor for HIV acquisition, it is our belief that this approach would also be effective in ameliorating HIV incidence and prevalence, especially in areas such as South and Southeast Asia and sub-Saharan Africa where HIV and T. vaginalis are endemic (United Nations, 2009; World Health Organization, 2001). www.intechopen.com

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Research integrity, Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Other · Consensus signal: Other
Teacher disagreement score0.362
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0010.003
Insufficient payload (model declined to judge)0.0000.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.048
GPT teacher head0.268
Teacher spread0.220 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueInTech eBooksSame topicReproductive tract infections researchFrench-language works237,207